Transfected Mouse Melanoma Lines That Express Various Levels of Human Melanoma-Associated Antigen p97
- 15 March 1989
- journal article
- research article
- Published by Oxford University Press (OUP) in JNCI Journal of the National Cancer Institute
- Vol. 81 (6) , 445-448
- https://doi.org/10.1093/jnci/81.6.445
Abstract
The gene for the human melanoma-associated antigen p97 has been introduced by cDNA transfection into cells from clone M2 of the K1735 mouse melanoma, which metastasizes to the lung when injected iv into syngeneic C3H/HeN mice. Tumor clones were established from the transfected cells and found to differ in the level of p97 expression. Their outgrowth in immuno-competent syngeneic mice was shown to inversely correlate with p97 antigen expression, and lines that express higher p97 levels elicited a stronger delayed-type hypersensitivity response when injected into the footpads of mice immune to p97. Five clones which expressed very high levels of p97 failed to grow in immunocompetent C3H/HeN mice, while they formed tumors in nude (nu/nu) mice. The highest expressing clone, 2A, grew slightly faster than any of the other clones when cultured in vitro. Since several of the transfected clones were found to express a stable level of p97 and have consistent in vivo growth behavior, they provide a useful model for various forms of antigen-specific active and passive immunotherapy with the same agents as those intended for human application. [J Natl Cancer Inst 81:445–448, 1989]This publication has 8 references indexed in Scilit:
- Recombinant vaccinia virus vaccine against the human melanoma antigen p97 for use in immunotherapy.Proceedings of the National Academy of Sciences, 1988
- Characterization of a recombinant vaccinia virus expressing human melanoma-associated antigen p97Journal of Virology, 1988
- Vaccines containing purified GM2 ganglioside elicit GM2 antibodies in melanoma patients.Proceedings of the National Academy of Sciences, 1987
- MONOCLONAL MOUSE ANTIBODIES RAISED AGAINST HUMAN-LUNG CARCINOMA1986
- PREPARATION AND CHARACTERIZATION OF A POLYVALENT HUMAN-MELANOMA ANTIGEN VACCINE1986
- Therapy of disseminated murine leukemia with cyclophosphamide and immune Lyt-1+,2- T cells. Tumor eradication does not require participation of cytotoxic T cells.The Journal of Experimental Medicine, 1985
- Structural characterization of human melanoma-associated antigen p97 with monoclonal antibodies.The Journal of Immunology, 1981
- BIOLOGICAL AND EXPERIMENTAL CONSEQUENCES OF THE ZONAL COMPOSITION OF SOLID TUMORS1981